ITCI - Intra-Cellular Therapies, Inc.

QQQ $ 439.55 $ -0.26 (-0.06 %)

DIA $ 390.50 $ 1.74 (0.45 %)

SPY $ 517.10 $ 0.05 (0.01 %)

TLT $ 90.18 $ -0.55 (-0.61 %)

GLD $ 213.58 $ -0.63 (-0.29 %)

Previous Close

$ 67

Open

$ 70.82

Bid

$ 0.00 x 0

Ask

$ 82.00 x 200

Day's Range

$ 66.98 - $ 70.87

52 Week Range

$ 45.50 - $ 84.89

Volume

977,604

Average Volume

Market Cap

6.49B

Beta (5Y Monthly)

$ 0.80

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-07-2024	03-31-2024	10-Q
2	02-22-2024	12-31-2023	10-K
3	11-02-2023	09-30-2023	10-Q
4	08-03-2023	06-30-2023	10-Q
5	05-04-2023	03-31-2023	10-Q
6	03-01-2023	12-31-2022	10-K
7	11-03-2022	09-30-2022	10-Q
8	08-09-2022	06-30-2022	10-Q
9	05-10-2022	03-31-2022	10-Q
10	03-01-2022	12-31-2021	10-K
11	11-09-2021	09-30-2021	10-Q
12	08-09-2021	06-30-2021	10-Q
13	05-10-2021	03-31-2021	10-Q
14	02-25-2021	12-31-2020	10-K
15	11-09-2020	09-30-2020	10-Q
16	08-10-2020	06-30-2020	10-Q
17	05-07-2020	03-31-2020	10-Q
18	03-02-2020	12-31-2019	10-K
19	11-05-2019	09-30-2019	10-Q
20	08-07-2019	06-30-2019	10-Q
21	05-08-2019	03-31-2019	10-Q
22	02-27-2019	12-31-2018	10-K
23	11-07-2018	09-30-2018	10-Q
24	08-02-2018	06-30-2018	10-Q
25	05-03-2018	03-31-2018	10-Q
26	03-01-2018	12-31-2017	10-K
27	11-08-2017	09-30-2017	10-Q
28	08-09-2017	06-30-2017	10-Q
29	05-10-2017	03-31-2017	10-Q
30	03-01-2017	12-31-2016	10-K
31	11-09-2016	09-30-2016	10-Q
32	08-04-2016	06-30-2016	10-Q
33	04-28-2016	03-31-2016	10-Q
34	04-28-2016	03-31-2016	10-Q
35	02-25-2016	12-31-2015	10-K
36	11-05-2015	09-30-2015	10-Q
37	08-05-2015	06-30-2015	10-Q
38	04-30-2015	03-31-2015	10-Q
39	03-12-2015	12-31-2014	10-K
40	11-03-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Analyst Ratings For Intra-Cellular Therapies
05/08/2024 20:00:33

Needham Reiterates Buy on Intra-Cellular T...
05/08/2024 09:42:09

Needham analyst Ami Fadia reiterates Intra-Cellular Therapies (NASDAQ:ITCI) with a Buy and maintains $90 price target.

Needham Reiterates Buy on Intra-Cellular T...
05/07/2024 12:29:07

Needham analyst Ami Fadia reiterates Intra-Cellular Therapies (NASDAQ:ITCI) with a Buy and maintains $90 price target.

Intra-cellular Therapies Reiterates Full Y...
05/07/2024 11:33:47

Intra-Cellular Therapies Q1 2024 GAAP EPS ...
05/07/2024 11:32:28

Cantor Fitzgerald Reiterates Overweight on...
04/24/2024 13:57:52

Cantor Fitzgerald analyst Charles Duncan reiterates Intra-Cellular Therapies (NASDAQ:ITCI) with a Overweight and maintains $...

Canaccord Genuity Maintains Buy on Intra-C...
04/23/2024 14:49:44

Canaccord Genuity analyst Sumant Kulkarni maintains Intra-Cellular Therapies (NASDAQ:ITCI) with a Buy and raises the price t...

Needham Maintains Buy on Intra-Cellular Th...
04/22/2024 16:44:41

Needham analyst Ami Fadia maintains Intra-Cellular Therapies (NASDAQ:ITCI) with a Buy and raises the price target from $82 t...

The Analyst Verdict: Intra-Cellular Therap...
04/22/2024 13:00:41

Mizuho Maintains Buy on Intra-Cellular The...
04/22/2024 11:11:36

Mizuho analyst Graig Suvannavejh maintains Intra-Cellular Therapies (NASDAQ:ITCI) with a Buy and raises the price target fro...

how-is-the-market-feeling-about-intra-cellular-therapies

How Is The Market Feeling About Intra-Cell...
04/19/2024 16:00:31

Reported Earlier, Intra-Cellular Therapies...
04/18/2024 07:42:49

All of the shares in the offering will be sold by Intra-Cellular Therapies, with gross proceeds to Intra-Cellular Therapies exp...

Goldman Sachs Maintains Neutral on Intra-C...
04/17/2024 15:31:29

Goldman Sachs analyst Corinne Jenkins maintains Intra-Cellular Therapies (NASDAQ:ITCI) with a Neutral and raises the price t...

B of A Securities Maintains Buy on Intra-C...
04/17/2024 11:59:13

B of A Securities analyst Jason Gerberry maintains Intra-Cellular Therapies (NASDAQ:ITCI) with a Buy and raises the price ta...

Baird Maintains Outperform on Intra-Cellul...
04/17/2024 11:35:48

Baird analyst Joel Beatty maintains Intra-Cellular Therapies (NASDAQ:ITCI) with a Outperform and raises the price target fro...

TD Cowen Maintains Buy on Intra-Cellular T...
04/17/2024 10:15:56

TD Cowen analyst Joseph Thome maintains Intra-Cellular Therapies (NASDAQ:ITCI) with a Buy and raises the price target from $...

Abbott Laboratories, U.S. Bancorp And 3 St...
04/17/2024 06:06:22

With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as ...

Intra-Cellular Therapies Announces $500M P...
04/16/2024 20:13:19

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) ("Intra-Cellular Therapies"), a biopharmaceutical company focused on the d...

Intra-Cellular Therapies Inc Files For Mix...
04/16/2024 20:06:56

- SEC Filing

why-skillsoft-shares-are-trading-lower-by-around-27-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why Skillsoft Shares Are Trading Lower By ...
04/16/2024 18:17:57

Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter...